Reuters logo
BRIEF-Bayer says sees closing of Merck & co OTC deal in second-half 2014
May 6, 2014 / 10:11 AM / 4 years ago

BRIEF-Bayer says sees closing of Merck & co OTC deal in second-half 2014

FRANKFURT, May 6 (Reuters) - Bayer AG : * Says buy Merck & co inc’s otc drugs business for$14.2 billion * Says acquisition will give it the global number two position in

non-prescription products * Says plans to finance acquisition with bridge facility provided by Bank of

America, Merrill Lynch, bnp paribas and mizuho, * Says sees closing in the second half of 2014. * Says entered into co-development and co-commercialization deal with Merck in

soluble guanylate cyclase (sgc) modulators

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below